Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
Neuromuscular Disorders : NMD|January 24, 2007
A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assayAstrid Milic, Nathalie Daniele, Hanns Lochmüller, et al.
Journal of Neurology|April 21, 2010
Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2Maggie C Walter, Birgit Czermin, Solvig Muller-Ziermann, et al.
Journal of Neurology|December 16, 2003
Variable reduction of caveolin-3 in patients with LGMD2B/MMMaggie C Walter, Christian Braun, Matthias Vorgerd, et al.
Neurology. Genetics|December 20, 2024
Updated Structure of CNBP Repeat Expansions in Patients With Myotonic Dystrophy Type 2 and Its Implication for Standard DiagnosticsMartin Wendlandt, Hannes Erdmann, Simone Rost, et al.
Neurological Research and Practice|December 15, 2022
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleAndré Maier, Matthias Boentert, Peter Reilich, et al.
Neuromolecular Medicine|November 18, 2015
The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory NeuropathySaranya Suriyanarayanan, Mari Auranen, Jussi Toppila, et al.
Neurogenetics|October 2, 2007
Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain diseaseUte Hehr, Goekhan Uyanik, Claudia Gross, et al.
Neuromuscular Disorders : NMD|May 16, 2018
A new case of limb girdle muscular dystrophy 2G in a Greek patient, founder effect and review of the literatureRoberta Brusa, Francesca Magri, Dimitra Papadimitriou, et al.
Pageof 17